Why is knowing a tumors origin important for patients receiving targeted cancer therapies?
Targeted therapies can be effective even with metastatic tumors and are generally tumor-specific (e.g., Herceptin® for breast cancer), but this requires identification of the primary tumor site/tissue of origin. Targeting therapy to specific tumor types may allow patients to avoid the toxicity of broad-spectrum, and in some cases ineffective, chemotherapy.
